Roundview Capital’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

Roundview Capital’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-58,709	Closed	-$1.19M	–	345
2025 Q3	$1.19M	Hold	58,709	–	–	0.08%	202
2025 Q2	$984K	Hold	58,709	–	–	0.07%	215
2025 Q1	$902K	Hold	58,709	–	–	0.07%	209
2024 Q4	$1.29M	Buy	58,709 +1,850	+3%	+$33.7K	0.09%	188
2024 Q3	$1.02M	Buy	56,859 +6,000	+12%	+$105K	0.07%	216
2024 Q2	$826K	Hold	50,859	–	–	0.07%	222
2024 Q1	$718K	Buy	50,859 +24,300	+91%	+$306K	0.06%	232
2023 Q4	$277K	Buy	+26,559	New	+$248K	0.03%	284

Other funds holding TEVA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

HIIFS

Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return

MMH

Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

MIFH

Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

LIM

Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return

Roundview Capital's TEVA Position: Q4 2025 in Review

Roundview Capital sold out of Teva Pharmaceutical Industries Limited (TEVA) in Q4 2025, closing a stake of 58,709 shares — an estimated $1.19M sold.

Roundview Capital first reported a position in TEVA in Q4 2023 and held it in 8 quarters. The position peaked at $1.29M in Q4 2024. 632 funds tracked by Wall St. Rank hold TEVA as of Q4 2025.

Roundview Capital reported no remaining Teva Pharmaceutical Industries Limited position as of Q4 2025 after selling out during the quarter.
Roundview Capital sold 58,709 Teva Pharmaceutical Industries Limited shares in Q4 2025, an estimated $1.19M.
Roundview Capital first reported a position in Teva Pharmaceutical Industries Limited in Q4 2023 and held it in 8 quarters.
Roundview Capital's Teva Pharmaceutical Industries Limited position peaked at $1.29M in Q4 2024.
632 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q4 2025.

Based on Roundview Capital's 13F filing for Q4 2025, filed 9 Feb 2026.